Wilmington, DE, United States of America

Patrick Thomas Cyr

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Patrick Thomas Cyr in Pain Management

Introduction: Patrick Thomas Cyr, an accomplished inventor located in Wilmington, DE, has made significant contributions to the field of pain management through his innovative work. With one patent to his name, Cyr is recognized for his efforts in developing new pharmaceutical formulations. His expertise is focused on the polymorphic forms of oxycodone, specifically designed to enhance analgesic properties.

Latest Patents: Cyr holds a patent for oxycodone polymorphs, detailing specific forms of oxycodone hydrochloride. These polymorphs are disclosed to be effective as analgesic agents, either in conjunction with or as substitutes for traditional oxycodone. This innovation showcases Cyr's commitment to improving pain management options for patients.

Career Highlights: Patrick Thomas Cyr is currently engaged with Noramco GmbH, where he continues to contribute to pharmaceutical innovations. His focus on developing new formulations highlights his dedication to enhancing patient care through scientific advancement.

Collaborations: Throughout his career, Cyr has had the opportunity to collaborate with notable colleagues such as Abram Calderon and Douglas Phillip Cox. These partnerships reflect a collaborative spirit within the research environment, fostering innovation that can lead to significant breakthroughs in the field.

Conclusion: As a prominent figure in the realm of pharmaceuticals, Patrick Thomas Cyr's work exemplifies the importance of innovation in developing effective pain management solutions. His patented work on oxycodone polymorphs not only demonstrates his expertise but also underscores the potential for improved therapeutic agents in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…